bioRxivImmunology
Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment
A. Papadas, G. Deb, A. Officer, A. Cicala, C. Hope, P. Emmerich, J. Wiesner, A. Pagenkopf, G. Arauz, V. Bansal, K. Matkowskyj, D. A. Deming, K. Politi, S. Abrams, O. Harismendy, F. Asimakopoulos
Abstract
Stimulatory dendritic cells (SDC), enriched within Batf3-DC (cDC1), engage in productive interactions with CD8+ effectors along tumor-stroma boundaries. The paradoxical accumulation of "poised" cross-presenting Batf3-DC within stromal sheets, distal to tumoral nests, is unlikely to simply reflect passive exclusion away from immunosuppressive tumor cores. Drawing parallels with embryonic morphogenesis, we hypothesized that invasive margin stromal remodeling may generate developmentally conserved cell-fate cues that regulate Batf3-DC behavior. We find that CD8+ T-cells massively infiltrate tumor matrices undergoing proteoglycan versican (VCAN) proteolysis, an essential organ-sculpting modification in development and adult tissue-plane forging. VCAN proteolysis releases a bioactive fragment (matrikine), versikine, that is necessary and sufficient for Batf3-DC accumulation. Versikine does not influence tumor-seeding pre-DC differentiation; rather, it orchestrates a distinctive activation program conferring exquisite sensitivity to DNA-sensing, coupled with survival support from atypical innate lymphoid cells. Thus, homeostatic signals from stroma invasion regulate SDC survival and activity to promote T- cell inflammation. HIGHLIGHTSO_LITumor stroma remodeling generates cross-presenting DC survival and activation cues. C_LIO_LIStromal-activated Batf3-DC are hypersensitive to dsDNA-sensing. C_LIO_LIStromal signals promote atypical innate lymphoid cells (GM-CSFhi/ IFN{gamma}lo). C_LIO_LIT-cell repriming by stroma-licensed Batf3-DC may overcome exclusion at tumor margins. C_LI
- organism: mouse
- assay: proteomics
- research focus: cell signaling & trafficking
- research focus: cancer & tumor microenvironment
- research focus: cell type annotation
- approach: experimental assay
- approach: genetic perturbation / CRISPR
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A matrikine organizes the dendritic cell- T cell triads that build tertiary lymphoid structures
Daniel J. Lagal, Duncan Hong, … Fotis A. Asimakopoulos·bioRxiv·Oct 29, 2026
- T cell priming is enhanced by maturation-dependent stiffening of the dendritic cell cortex
D. Blumenthal, V. Chandra, … J. K. Burkhardt·bioRxiv·Feb 16, 2020
- Mechanical licensing of functional dendritic cell states for enhanced T cell priming
Yi Chen, Amanda S. Bluem, … Kyle H. Vining·bioRxiv·May 23, 2026
- Successful dendritic cell vaccines require lasting in-situ TNF α secretion to license antitumor CD8 + T cell cytotoxicity
Nadine Santana-Magal, Aseel Khateeb, … Yaron Carmi·bioRxiv·Apr 8, 2026
- STING Licensing of Type I Dendritic Cells Potentiates Antitumor Immunity
- In Vitro Maturation of Bone Marrow-Derived Dendritic Cells via STING Activation for T Cell Priming
Busra Buyuk, Kaiming Ye·CancersPeer-reviewed·Oct 30, 2025